Disc Medicine (IRON): Director sold ~$498K
ORBIMED ADVISORS LLC, Director at Disc Medicine, sold ~$498K of Disc Medicine shares.
- ~$498K
- Approx. value · 9,222 sh @ $54.01
- 530K
- Holds after · shares reported
- Traded
- Mar 11, 2025
- Filed
- Mar 13, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Feb 3, 2025Insider · 1 personInsiders: 2 sales (~$417K)
- Feb 18, 2025Insider · 6 peopleInsiders: 6 sales (~$887K)
- Mar 10, 2025Insider · 2 peopleInsiders: 12 sales (~$21.9M)
- Mar 11, 2025 · this disclosureInsiderDirector sold ~$498K of IRON shares in the open market
What came next
- Mar 11, 2025Insider · 2 peopleInsiders: 5 sales (~$2.4M)
- Mar 12, 2025Insider · 2 peopleInsiders: 12 sales (~$9.1M)
- Mar 19, 2025Insider · 2 peopleInsiders: 6 sales (~$4.3M)
- Mar 20, 2025Insider · 2 peopleInsiders: 6 sales (~$298K)
- Mar 21, 2025Insider · 2 peopleInsiders: 6 sales (~$1.1M)
- Mar 24, 2025Insider · 2 peopleInsiders: 6 sales (~$621K)
- May 2, 2025InsiderOfficer sold ~$105K of IRON shares in the open market
- May 20, 2025InsiderOfficer sold ~$334K of IRON shares in the open market
- Jun 6, 2025InsiderOfficer sold ~$150K of IRON shares in the open market
- Jun 16, 2025InsiderCFO sold ~$105K of IRON shares in the open market
- Jul 3, 2025InsiderCEO sold ~$286K of IRON shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Disc Medicine
For Disc Medicine, OQRO holds 23 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IRON page.
Other recent filings by ORBIMED ADVISORS LLC, Director
- SEC Form 4 at Electra Therapeutics (ETRA)Nov 11, 2026
- SEC Form 4 at Electra Therapeutics (ETRA)Nov 11, 2026
- SEC Form 4 at Electra Therapeutics (ETRA)Nov 11, 2026
- SEC Form 4 at Electra Therapeutics (ETRA)Nov 11, 2026
- SEC Form 4 at Electra Therapeutics (ETRA)Nov 11, 2026
The full history of ORBIMED ADVISORS LLC, Director is on the profile page.
How this filing works
Explore the data
Other disclosures at Disc Medicine
- SEC Form 4Nov 12, 2026
- SEC Form 144Nov 10, 2026
- SEC Schedule 13DOct 26, 2026
- SEC Form 144Oct 21, 2026
- SEC Form 144Oct 21, 2026
- SEC Form 144Oct 21, 2026
Everything OQRO holds on this company is on its IRON page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data